Related Experiment Video

Updated: Apr 19, 2026

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

7.9K

Tumors STING adaptive antitumor immunity

Vincenzo Bronte1

  • 1Verona University Hospital and Department of Pathology and Diagnostics, University of Verona, 37134 Verona, Italy.

Immunity
|December 18, 2014
PubMed

Insights

Dendritic cells recognize tumor DNA through the STING-mediated cytosolic DNA sensing pathway. This discovery sheds light on tumor immunogenicity and cancer immunotherapy.

Area of Science:

  • Immunology
  • Cancer Biology
  • Molecular Biology

Background:

  • Immunotherapy offers promising cancer treatment, but the underlying molecular mechanisms of tumor immunogenicity remain incompletely understood.
  • Identifying how the immune system recognizes tumor cells is crucial for advancing cancer therapies.

Purpose of the Study:

  • To investigate the molecular mechanisms by which dendritic cells detect DNA originating from tumor cells.
  • To elucidate the role of cytosolic DNA sensing pathways in initiating anti-tumor immune responses.

Main Methods:

  • The study likely involved experiments with dendritic cells and tumor-derived DNA.
  • Investigated the involvement of the STING (Stimulator of Interferon Genes) protein in the DNA sensing pathway.

Main Results:

  • Evidence suggests that dendritic cells utilize the STING-mediated pathway to detect DNA from tumor cells.
  • This pathway appears to be a key component in the innate immune recognition of cancer cells.

Conclusions:

  • The STING-mediated cytosolic DNA sensing pathway is implicated in recognizing tumor-derived DNA by dendritic cells.
  • This finding contributes to understanding tumor immunogenicity and provides potential targets for enhancing cancer immunotherapy.

More Related Videos

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

2.0K
Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis07:45

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis

Published on: January 26, 2024

3.0K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.6K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

3.2K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
8.5K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
88.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.6K